Search Results - "Benitez-Ribas, Daniel"

This result is not displayed to guests.
Login for full access.

Phase II randomised trial of autologous tumour lysate dendritic cell plus best supportive care compared with best supportive care in pre-treated advanced colorectal cancer patients.

Authors: Caballero-Baños, Miguel Benitez-Ribas, Daniel Tabera, Jaime et al.

Source: European Journal of Cancer. Sep2016, Vol. 64, p167-174. 8p.

Combining CAR T-Cell Therapy and Nivolumab to Overcome Immune Resistance in THRLBCL: A Case Report.

Authors: Munarriz, Daniel López-Godino, Oriana Martinez-Cibrian, Nuria et al.

Source: International Journal of Molecular Sciences. Oct2025, Vol. 26 Issue 19, p9265. 8p.

Dendritic Cells as Vaccines: Key Regulators of Tolerance and Immunity.

Authors: Tel, Jurjen Benitez-Ribas, Daniel Janssen, Edith M. et al.

Source: Mediators of Inflammation. 5/31/2016, p1-2. 2p.

Prophylactic vaccines mimic synthetic CpG oligonucleotides in their ability to modulate immune responses

Authors: de Vries, I. Jolanda M. Tel, Jurjen Benitez-Ribas, Daniel et al.

Source: Molecular Immunology. Mar2011, Vol. 48 Issue 6/7, p810-817. 8p.

Placental Microparticles and MicroRNAs in Pregnant Women with Plasmodium falciparum or HIV Infection.

Authors: Moro, Laura Bardají, Azucena Macete, Eusebio et al.

Source: PLoS ONE. 1/12/2016, Vol. 11 Issue 1, p1-17. 17p.

Gram-Negative Enterobacteria Induce Tolerogenic Maturation in Dexamethasone Conditioned Dendritic Cells.

Authors: Cabezón, Raquel Ricart, Elena España, Carolina et al.

Source: PLoS ONE. Dec2012, Vol. 7 Issue 12, p1-13. 13p.

Vaccines for Non-Viral Cancer Prevention.

Authors: Bayó, Cristina Jung, Gerhard Español-Rego, Marta et al.

Source: International Journal of Molecular Sciences. Oct2021, Vol. 22 Issue 20, p10900. 1p.

3083 – SINGLE CELL MULTIOMIC ANALYSIS OF CLONAL AND TRANSCRIPTIONAL PROGRAMS OF CD19 CAR T CELLS IN THE IMMUNOTHERAPY RESPONSE.

Authors: Murillo, Mercedes Guerrero Rill-Hinarejos, Aina Trincado, Juan L et al.

Source: Experimental Hematology. 2024 Supplement, Vol. 137, pN.PAG-N.PAG. 1p.

In vivo tracking and immunological properties of pulsed porcine monocyte-derived dendritic cells.

Authors: Crisci, Elisa Fraile, Lorenzo Novellas, Rosa et al.

Source: Molecular Immunology. Feb2015, Vol. 63 Issue 2, p343-354. 12p.

Natural Human Plasmacytoid Dendritic Cells Induce Antigen-Specific T-Cell Responses in Melanoma Patients.

Authors: Tel, Jurjen Aarntzen, Erik H. J. G. Baba, Tetsuro et al.

Source: Cancer Research. Feb2013, Vol. 73 Issue 3, p1063-1075. 13p.

Analysis of HLDA9 mAbs on plasmacytoid dendritic cells

Authors: Cabezón, Raquel Sintes, Jordi Llinàs, Laia et al.

Source: Immunology Letters. Jan2011, Vol. 134 Issue 2, p167-173. 7p.

Toll-like receptor expression and function in human dendritic cell subsets: implications for dendritic cell-based anti-cancer immunotherapy.

Authors: Schreibelt, Gerty Tel, Jurjen Sliepen, Kwinten H. E. E. J. et al.

Source: Cancer Immunology, Immunotherapy. Oct2010, Vol. 59 Issue 10, p1573-1582. 10p.

Polyinosinic polycytidylic acid prevents efficient antigen expression after mRNA electroporation of clinical grade dendritic cells.

Authors: Schuurhuis, Danita H. Lesterhuis, W. Joost Kramer, Matthijs et al.

Source: Cancer Immunology, Immunotherapy. Jul2009, Vol. 58 Issue 7, p1109-1115. 7p. 2 Graphs.

Maturation of monocyte-derived dendritic cells with Toll-like receptor 3 and 7/8 ligands combined with prostaglandin E2 results in high interleukin-12 production and cell migration.

Authors: Boullart, A. C. Inge Aarntzen, Erik H. J. Verdijk, Pauline et al.

Source: Cancer Immunology, Immunotherapy. Nov2008, Vol. 57 Issue 11, p1589-1597. 9p. 5 Graphs.

Personalized tumor-loaded monocyte-derived dendritic cell vaccination in combination with atezolizumab as maintenance treatment in extensive-stage small cell lung cancer (ES-SCLC): phase Ib-II VENEZOLUNG trial.

Authors: Gonzalez-Cao M Sisteré-Oró M Moran T et al.

Source: Journal for immunotherapy of cancer [J Immunother Cancer] 2026 Jul 24; Vol. 14 (7). Date of Electronic Publication: 2026 Jul 24.

Publication Type: Journal Article; Clinical Trial, Phase II; Clinical Trial, Phase I

Journal Info: Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Electronic Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE

Proteins of the cancer cell secretome induce the protumoral microenvironment of diffuse intrinsic pontine glioma.

Authors: Baulenas-Farres M Paco S Marino F et al.

Source: Neuro-oncology advances [Neurooncol Adv] 2025 Jun 19; Vol. 7 (1), pp. vdaf132. Date of Electronic Publication: 2025 Jun 19 (Print Publication: 2025).

Publication Type: Journal Article

Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 101755003 Publication Model: eCollection Cited Medium: Internet ISSN: 2632-2498 (Electronic) Linking ISSN: 26322498 NLM ISO Abbreviation: Neurooncol Adv Subsets: PubMed not MEDLINE

Discovery and validation of frameshift-derived neopeptides in Lynch syndrome: paving the way for novel cancer prevention strategies.

Authors: Bayó C Castellano G Marín F et al.

Source: Journal for immunotherapy of cancer [J Immunother Cancer] 2025 Apr 20; Vol. 13 (4). Date of Electronic Publication: 2025 Apr 20.

Publication Type: Journal Article

Journal Info: Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Electronic Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE

Identification of immunosuppressive factors in retinoblastoma cell secretomes and aqueous humor from patients.

Authors: Cuadrado-Vilanova M Liu J Paco S et al.

Source: The Journal of pathology [J Pathol] 2022 Jul; Vol. 257 (3), pp. 327-339. Date of Electronic Publication: 2022 Apr 13.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: John Wiley And Sons Country of Publication: England NLM ID: 0204634 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1096-9896 (Electronic) Linking ISSN: 00223417 NLM ISO Abbreviation: J Pathol Subsets: MEDLINE

Direct In Vivo Activation of T Cells with Nanosized Immunofilaments Inhibits Tumor Growth and Metastasis.

Authors: Weiss L Weiden J Dölen Y et al.

Source: ACS nano [ACS Nano] 2023 Jul 11; Vol. 17 (13), pp. 12101-12117. Date of Electronic Publication: 2023 Jun 20.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: American Chemical Society Country of Publication: United States NLM ID: 101313589 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1936-086X (Electronic) Linking ISSN: 19360851 NLM ISO Abbreviation: ACS Nano Subsets: MEDLINE